BioWorld

June 28, 2004

View Archived Issues

Bush Administration Feels More Pressure Over ESCs

Read More

Medarex Paying $4.7M To Acquire Ability Biomedical

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More

Vectura Completes IPO On London's AIM, Raises £20M

About seven years since its inception, Vectura Ltd. dipped its feet into public waters on Friday, conducting an initial public offering on London's Alternative Investment Market to raise £20 million (US$36.4 million). (BioWorld Today) Read More